---
figid: PMC6108217__NRR-13-1332-g001
figlink: /pmc/articles/PMC6108217/figure/F1/
number: Figure 1
caption: 'Proposed anti-inflammatory mechanism of action of noradrenaline/β2-adrenoceptor
  (β2-AR) agonists on nigral microglia in the inflamed substantia nigra; a molecular
  signalling pathway towards neuroprotection.Stimulation of Toll-like receptor 4 (TLR4)
  receptors on microglia with lipopolysaccharide (LPS) triggers a signalling cascade
  which leads to the phosphorylation and subsequent degradation of nuclear factor
  of kappa light polypeptide gene enhancer in B-cells inhibitor α (IκBα), nuclear
  factor-κB (NfκB) nuclear translocation and ensuing increases in pro-inflammatory
  gene expression. In the current schematic, stimulation of the β2-AR with endogenous
  noradrenergic (NA) or with a β2-AR agonist (e.g., clenbuterol/formoterol) may suppress
  NfκB transcriptional activity via the following pathway: (1) Stimulation of glial
  β2-ARs activates adenylyl cyclase which raises intracellular cyclic adenosine monophosphate
  (cAMP) leading to (2) activation of protein kinase A (PKA) which in turn phosphorylates
  cAMP-response element binding protein (CREB) and (3) induces de novo synthesis of
  the NfκB inhibitory protein IκBα (and possibly preventing its phosphorylation),
  thus stabilizing cytosolic levels of IκBα which (4) inhibits transcriptional activity
  of NfκB by preventing its translocation into the nucleus, ultimately (5) decreasing
  pro-inflammatory gene expression. TNFα: Tumor necrosis factor-α; IL: interleukin;
  iNOS: inducible nitric oxide synthase.'
pmcid: PMC6108217
papertitle: 'Targeting the noradrenergic system for anti-inflammatory and neuroprotective
  effects: implications for Parkinson''s disease.'
reftext: Eoin O’Neill, et al. Neural Regen Res. 2018 Aug;13(8):1332-1337.
pmc_ranked_result_index: '46644'
pathway_score: 0.9770298
filename: NRR-13-1332-g001.jpg
figtitle: 'Targeting the noradrenergic system for anti-inflammatory and neuroprotective
  effects: implications for Parkinson''s disease.'
year: '2018'
organisms: Homo sapiens
ndex: 45bebd35-debb-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6108217__NRR-13-1332-g001.html
  '@type': Dataset
  description: 'Proposed anti-inflammatory mechanism of action of noradrenaline/β2-adrenoceptor
    (β2-AR) agonists on nigral microglia in the inflamed substantia nigra; a molecular
    signalling pathway towards neuroprotection.Stimulation of Toll-like receptor 4
    (TLR4) receptors on microglia with lipopolysaccharide (LPS) triggers a signalling
    cascade which leads to the phosphorylation and subsequent degradation of nuclear
    factor of kappa light polypeptide gene enhancer in B-cells inhibitor α (IκBα),
    nuclear factor-κB (NfκB) nuclear translocation and ensuing increases in pro-inflammatory
    gene expression. In the current schematic, stimulation of the β2-AR with endogenous
    noradrenergic (NA) or with a β2-AR agonist (e.g., clenbuterol/formoterol) may
    suppress NfκB transcriptional activity via the following pathway: (1) Stimulation
    of glial β2-ARs activates adenylyl cyclase which raises intracellular cyclic adenosine
    monophosphate (cAMP) leading to (2) activation of protein kinase A (PKA) which
    in turn phosphorylates cAMP-response element binding protein (CREB) and (3) induces
    de novo synthesis of the NfκB inhibitory protein IκBα (and possibly preventing
    its phosphorylation), thus stabilizing cytosolic levels of IκBα which (4) inhibits
    transcriptional activity of NfκB by preventing its translocation into the nucleus,
    ultimately (5) decreasing pro-inflammatory gene expression. TNFα: Tumor necrosis
    factor-α; IL: interleukin; iNOS: inducible nitric oxide synthase.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CREB3L4
  - CREB3L2
  - NFKBIA
  - CREB3
  - CREB1
  - ATF2
  - PRKAR1A
  - ATF1
  - PRKACA
  - PRKACG
  - NFKB1
  - CREM
  - IL1B
  - IL6
  - PRKAR2A
  - PRKAR2B
  - CREB5
  - PRKACB
  - REL
  - CREB3L3
  - PRKAR1B
  - RELB
  - NFKB2
  - ADRB2
  - CREB3L1
  - TNF
  - RELA
  - Adenylyl
genes:
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L4
  entrez: '148327'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L2
  entrez: '64764'
- word: IKBA
  symbol: IkappaBalpha
  source: hgnc_alias_symbol
  hgnc_symbol: NFKBIA
  entrez: '4792'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3
  entrez: '10488'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB1
  entrez: '1385'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF2
  entrez: '1386'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF1
  entrez: '466'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: NfkB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREM
  entrez: '1390'
- word: IL-1B,
  symbol: IL-1B
  source: hgnc_alias_symbol
  hgnc_symbol: IL1B
  entrez: '3553'
- word: IL-6
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB5
  entrez: '9586'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: NfkB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L3
  entrez: '84699'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: NfkB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: NfkB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: B2-AR
  symbol: B2AR
  source: hgnc_alias_symbol
  hgnc_symbol: ADRB2
  entrez: '154'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L1
  entrez: '90993'
- word: TNFA,
  symbol: TNF-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: NfkB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
chemicals:
- word: Adenylyl
  source: MESH
  identifier: C015492
diseases: []
---
